GLUE EBITDA Margin
Monte Rosa Therapeutics Inc · EBITDA Margin
GLUE EBITDA Margin
Latest reported-542.51%period ending
GLUE EBITDA Margin (0.00% → -542.51%)
Annual ebitda margin
High-resolution chart · PNG
GLUE ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -25.3631% | |
| -81.9986% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |